# Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma

> **NCT06932861** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Xinxin Zhang** · enrollment: 5 (estimated)

## Conditions studied

- Rhabdomyosarcoma

## Interventions

- **BIOLOGICAL:** mRNA Tumor Vaccine Therapy

## Key facts

- **NCT ID:** NCT06932861
- **Lead sponsor:** Xinxin Zhang
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2027-05-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2025-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06932861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06932861, "Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06932861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*